News from Cambridge Enterprise.
Apollo Therapeutics, a biopharmaceutical company originally set up by three UK universities (Cambridge, Imperial College London and University College London) and three pharmaceutical companies (AstraZeneca, GSK and Johnson & Johnson Innovation), has secured $226.5 million venture capital financing.
Co-founder and CEO of Start Codon, Jason Mellad on helping healthcare start-ups thrive and why inclusion and diversity will change the world.
Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, marked its 15th anniversary with a remarkable series of achievements.
Researchers have developed a new design for computer memory that could both greatly improve performance and reduce the energy demands of internet and communications technologies, which are predicted to consume nearly a third of global electricity within the next ten years.
Cambridge architects have won a public choice award at the London Design Biennale for a prototype home constructed with flexible wooden partition walls which can be shifted to meet the changing needs of residents. The invention aims to reduce waste and carbon while also improving living conditions for those who cannot afford expensive refurbishments.
Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against SARS-CoV-2 – the virus that causes COVID-19 – and related coronaviruses.
The University contributes nearly £30 billion to the UK economy and supports more than 86,000 jobs across the UK, according to a new report.
A team of student entrepreneurs who see algae as a potential business solution for reducing methane emissions from landfill and waste-water sites won the 2023 Cambridge Zero Climate Challenge after a nail-biting competition.
A new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, and gives highly accurate results in under an hour, has been developed by Cambridge researchers.
100 organisations, including AstraZeneca, Microsoft and Arm, have signed up to a new charter to boost the Cambridge innovation ecosystem and help it address global challenges, announced Innovate Cambridge today (8 December 2022).
© 2024 University of Cambridge
